# Prospective Evaluation of Intrathecal Targeted Drug Delivery for Cancer Associated Pain

> **NCT05674240** · — · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 30 (actual)

## Conditions studied

- Cancer Pain
- Chronic Pain
- Cancer Associated Pain
- Neuropathic Pain

## Interventions

- **DEVICE:** Intrathecal Targeted Drug Delivery
- **COMBINATION_PRODUCT:** Conservative medical management

## Key facts

- **NCT ID:** NCT05674240
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-06
- **Primary completion:** 2026-03-20
- **Final completion:** 2026-03-20
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05674240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05674240, "Prospective Evaluation of Intrathecal Targeted Drug Delivery for Cancer Associated Pain". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05674240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*